The Valley Desk

NCT06423911 · Interventional trial

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Overall registry status Recruiting

Phase 3

Conditions CML, CML, Chronic Phase, Chronic Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov